MedTrace Logo

Timing of Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy

NCT07636135 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether starting rehabilitation earlier after surgery can improve recovery and is feasible and acceptable for adults with degenerative cervical myelopathy (DCM) undergoing cervical spine surgery. The main question it aims to answer is:

Does starting rehabilitation earlier improve walking, balance, physical activity, quality of life, and nervous system function after surgery?

Researchers will compare participants who begin rehabilitation two weeks after surgery with participants who begin rehabilitation six weeks after surgery to see if earlier rehabilitation leads to better recovery outcomes and participation.

Participants will:

Be randomly assigned to begin rehabilitation either two weeks or six weeks after surgery.

Attend physical therapy sessions twice per week for eight weeks focused on strength, balance, and walking.

Complete assessments of walking ability, balance, physical activity, quality of life, and nervous system function over several months after surgery.

Provide feedback about their experience with the rehabilitation program, including satisfaction and any side effects or challenges related to participation.

Conditions

  • Cervical Myelopathy

Interventions

BEHAVIORAL

Physical Therapy

Active, task-specific physical therapy to enhance balance, walking, and strength

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-10-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07636135 on ClinicalTrials.gov